InsiderTrades

Form 4 for LIF Life360, Inc.

Accepted 2026-07-15 17:49:31 ET · period of report 2026-07-13 · accession 0001581760-26-000124 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-07-15 17:49 2026-07-13 LIF Prober Charles J. Dir M - OptEx $11.18 +7,930 117.8K +7% +$88.7K
DT 2026-07-15 17:49 2026-07-13 LIF Prober Charles J. Dir S - Sale+OE $53.05 -7,930 109.9K -7% -$420.7K
DT 2026-07-15 17:49 2026-07-13 LIF Prober Charles J. Dir M - OptEx $0.00 -7,930 31.7K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common stock 2026-07-13 M A 7,930 $11.18 117,841 D — — (F1) The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. (F2) Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
2 Common Common stock 2026-07-13 S D 7,930 $53.05 109,911 D — — (F1) The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. (F2) Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
3 Derivative Stock Option (right to buy) 2026-07-13 M D 7,930 $0.00 31,720 D $11.18 · — to 2028-04-12 7,930 Common stock (F1) The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. (F3) The stock option is fully vested and exercisable.